Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1; no visible changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Locations entries for Arizona, Louisiana, Massachusetts, Michigan, Missouri, New Jersey, New York, Texas, and Washington, and removed their state-specific location sections; revision updated to v3.3.3.SummaryDifference0.8%

- Check91 days agoChange DetectedThe Publications note text was updated to clarify PubMed auto-filling and the revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe government funding operating-status notice was removed from the page. The removed notice instructed users to check cc.nih.gov and opm.gov for updates.SummaryDifference0.3%

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.